会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • 신규한 몰피난 유도체
    • 신규한몰피난유도체
    • KR100425881B1
    • 2004-04-03
    • KR1020010013173
    • 2001-03-14
    • 김형춘고광호최신건주왕기신은주이필호
    • 김형춘주왕기이필호고광호최신건신은주
    • C07D221/28
    • PURPOSE: Provided is a method for manufacturing a morphinan derivative which is very effective in preventing cramps and protecting nerves by changing groups at C3 and C17 of morphinan. CONSTITUTION: The method for manufacturing a morphinan derivative of the formula (1) comprises the next steps of: i) methylating dextrometrophan hydrobromide to obtain dextrophan of the formula (3); ii) reacting dextrophan with cyclopropylmethyl bromide or aryl bromide in the presence of hydride sodium to manufacture 3-cyclopropylmethoxy-17-methylmorphinan and 3-aryloxy-17-methylmorphinan; and iii) reacting 3-aryloxy-17-methylmorphinan with 1-chloroethyl chloroformate to obtain 3-aryloxymorphinan of the formula (5). In the formula, R is cyclopropylmethyl or aryl group. R' is a methyl group when R is a cyclopropylmethyl group and is hydrogen when R is an aryl group.
    • 目的:提供一种吗啡喃衍生物的制备方法,它通过改变吗啡喃的C3和C17基团而在预防痉挛和保护神经方面非常有效。 构成:制备式(1)的吗啡喃衍生物的方法包括以下步骤:i)甲基化右啡索酸氢溴酸以获得式(3)的右啡肽; ii)在氢化钠存在下,将右旋氯丙烷与环丙基甲基溴或芳基溴化物反应,制备3-环丙基甲氧基-17-甲基吗啡喃和3-芳氧基-17-甲基吗啡喃; 和iii)使3-芳氧基-17-甲基吗啡喃与氯甲酸1-氯乙酯反应,得到式(5)的3-芳氧基吗啡喃。 在该式中,R是环丙基甲基或芳基。 当R是环丙基甲基时,R'是甲基,而当R是芳基时,R'是氢。
    • 2. 发明公开
    • 신규한 몰피난 유도체
    • 制造新奇莫衍生物的方法
    • KR1020010044661A
    • 2001-06-05
    • KR1020010013173
    • 2001-03-14
    • 김형춘고광호최신건주왕기신은주이필호
    • 김형춘주왕기이필호고광호최신건신은주
    • C07D221/28
    • PURPOSE: Provided is a method for manufacturing a morphinan derivative which is very effective in preventing cramps and protecting nerves by changing groups at C3 and C17 of morphinan. CONSTITUTION: The method for manufacturing a morphinan derivative of the formula (1) comprises the next steps of: i) methylating dextrometrophan hydrobromide to obtain dextrophan of the formula (3); ii) reacting dextrophan with cyclopropylmethyl bromide or aryl bromide in the presence of hydride sodium to manufacture 3-cyclopropylmethoxy-17-methylmorphinan and 3-aryloxy-17-methylmorphinan; and iii) reacting 3-aryloxy-17-methylmorphinan with 1-chloroethyl chloroformate to obtain 3-aryloxymorphinan of the formula (5). In the formula, R is cyclopropylmethyl or aryl group. R' is a methyl group when R is a cyclopropylmethyl group and is hydrogen when R is an aryl group.
    • 目的:提供吗啡喃衍生物的制备方法,其通过改变吗啡喃的C3和C17的基团非常有效地预防痉挛和保护神经。 构成:制备式(1)的吗啡喃衍生物的方法包括以下步骤:i)甲基化右美沙芬氢溴酸盐,得到式(3)的右旋糖酐; ii)在氢化钠存在下使右旋丙醚与环丙基甲基溴或芳基溴反应,制备3-环丙基甲氧基-17-甲基吗啡喃和3-芳氧基-17-甲基吗啡喃; 和iii)使3-芳氧基-17-甲基吗啡喃与氯甲酸1-氯乙酯反应,得到式(5)的3-芳氧基吗啡喃。 在该式中,R是环丙基甲基或芳基。 当R为环丙基甲基时,R'为甲基,当R为芳基时,R'为氢。